Shared more. Cited more. Safe forever.
    • advanced search
    • submit works
    • about
    • help
    • contact us
    • login
    View Item 
    •   MOspace Home
    • University of Missouri-Columbia
    • Health Sciences Research Day (MU)
    • 2009 Health Sciences Research Day (MU)
    • View Item
    •   MOspace Home
    • University of Missouri-Columbia
    • Health Sciences Research Day (MU)
    • 2009 Health Sciences Research Day (MU)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    advanced searchsubmit worksabouthelpcontact us

    Browse

    All of MOspaceCommunities & CollectionsDate IssuedAuthor/ContributorTitleIdentifierThesis DepartmentThesis AdvisorThesis SemesterThis CollectionDate IssuedAuthor/ContributorTitleIdentifierThesis DepartmentThesis AdvisorThesis Semester

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular AuthorsStatistics by Referrer

    Multifunctional contrast agenst for molecular imaging of prostate cancer [abstract]

    Zhai, Huifang
    View/Open
    [PDF] MultifunctionalContrastAgentsMolecular[abstract].pdf (18.22Kb)
    Date
    2010-03
    Contributor
    University of Missouri--Columbia. School of Medicine
    Format
    Abstract
    Metadata
    [+] Show full item record
    Abstract
    Development of efficacious receptor-targeting contrast agents is particularly important for early detection of prostate cancers. When using non-invasive magnetic resonance imaging (MRI) for molecular imaging, sensitivity and specificity are critical issues. A multimodal approach such as MRI/optical and MRI/positron emission tomography can solve the problems associated with individual imaging modality. In our previous study, a near-infrared fluorescent bombesin (BBN) conjugate, AlexaFluro680-BBN[7-14], has shown high efficacy for gastrin releasing peptide receptor (GRPR) targeted imaging in human cancer mouse models. In this work, we report results on the synthesis and characterization of hybrid nanoparticle contrast agents AlexaFluro750-BBN[7-14]-SPIO and Gd-DOTA-BBN[7-14]-SPIO for dual-modality molecular imaging of prostate cancers. The nanoparticles consist of a biocompatible super-paramagnetic iron oxide (SPIO) core and AlexaFluro750-BBN or Gd-DOTA-BBN conjugates on the surface of SPIO. The characterizations were performed by IC50 (the half maximal inhibitory concentration), Prussian-blue staining reaction, atomic force microscope (AFM) imaging and fluorescence microscopic imaging in PC-3 prostate cancer cells. MRI relaxivity enhancements were determined using spin-echo sequences on 7T MRI. In vitro and in vivo imaging efficacy was evaluated and compared to non-targeted contrast agents, i.e. Gd-DTPA and SPIO, using MRI/optical imaging in PC-3 cells and SCID tumor xenografts. Our results show that the BBN-based multifunctional SPIO nanoparticles demonstrated high binding affinity and specificity and subsequent retention of the ligands in GRPR over-expressing prostate cancer cells via agonist initiated receptor-mediated endocytosis. This agonist initiated receptor-mediated endocytosis approach may offer a dynamic mechanism on nanoparticle accumulation and signal amplifications in cancer cells.
    URI
    http://hdl.handle.net/10355/6364
    Rights
    OpenAccess.
    This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.
    Collections
    • 2009 Health Sciences Research Day (MU)

    Send Feedback
    hosted by University of Missouri Library Systems
     

     


    Send Feedback
    hosted by University of Missouri Library Systems